<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0024796" disease_type="Disease or Syndrome" abbrv="MFS|MFS1">Marfan syndrome</z:e> is an <z:hpo ids='HP_0000006'>autosomal dominant</z:hpo> <z:e sem="disease" ids="C0009782" disease_type="Disease or Syndrome" abbrv="">disorder of connective tissue</z:e> characterized by abnormalities involving the skeletal, ocular, and cardiovascular systems </plain></SENT>
<SENT sid="1" pm="."><plain>The cardiovascular complications of the syndrome lead to a reduced life expectancy for affected individuals if left untreated </plain></SENT>
<SENT sid="2" pm="."><plain>Major cause of <z:hpo ids='HP_0011420'>death</z:hpo> include <z:hpo ids='HP_0011009'>acute</z:hpo> <z:hpo ids='HP_0002647'>aortic dissection</z:hpo>, <z:e sem="disease" ids="C0003496" disease_type="Disease or Syndrome" abbrv="">aortic rupture</z:e>, and <z:hpo ids='HP_0001699'>sudden death</z:hpo>, which resulted from congenital <z:e sem="disease" ids="C0854443" disease_type="Disease or Syndrome" abbrv="">vascular fragility</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>Such life-threatening complications in <z:e sem="disease" ids="C0024796" disease_type="Disease or Syndrome" abbrv="MFS|MFS1">Marfan syndrome</z:e> can be managed effectively, by routine aortic imaging, beta-adrenergic blockade, and prophylactic replacement of the aortic root before the diameter exceeds 5.0 to 5.5 mm </plain></SENT>
<SENT sid="4" pm="."><plain>Valve preserving aortic root reconstruction yielded improved postoperative quality of life compared with Bentall operation, by reducing late complications related to <z:chebi fb="2" ids="50249">anticoagulants</z:chebi> </plain></SENT>
<SENT sid="5" pm="."><plain>It should be carried out before <z:hpo ids='HP_0003674'>onset</z:hpo> of <z:hpo ids='HP_0001659'>aortic regurgitation</z:hpo> for long-term native valve durability </plain></SENT>
</text></document>